MyVisionTest News Archive

Displaying news items tagged with combo therapy (More tags »)
SELECT PAGE
First <<  1 2 3 4   >> Last

Visudyne
Nov 24, 2009
Intravitreal triamcinolone acetonide (ITA) does not improve the visual outcome of verteprofin photodynamic therapy (VPDT) for neovascular age-related macular degeneration (AMD), according to a new study. After the introduction of verteporfin for the treatment of subfoveal choroidal neovascularization (CNV), consideration was given to improving...

Full Article


Lucentis
Nov 17, 2009
Same-day verteporfin photodynamic therapy (PDT) and intravitreal Lucentis (ranibizumab) is safe and effective in the treatment of patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), according to a new study. In this open-label, prospective study patients received verteporfin PDT at...

Full Article


Radiation warning symbol
Oct 22, 2009
The use of epimacular brachytherapy (radiation) combined with Avaastin (bevacizumab) appears safe for treatment of neovascular age-related macular degeneration and reduces the dosing burden of anti-VEGF therapy. After 2 years of follow-up in 34 patients treated with strontium 90 and Avastin in a phase 2 study, 80% of patients who had cataract...

Full Article


Pigment epithelial detachment
Jul 20, 2009
Combined photodynamic therapy (PDT) and intravitreal Avastin (bevacizumab) injection is effective in the treatment of serous pigment epithelial detachment (PED) associated with age-related macular degeneration (AMD), according to a new study. A PED occurs when fluid enters the space between the retinal pigment epithelium (RPE) and choroid (...

Full Article


Macular degeneration
Jun 19, 2009
A new study finds that triple therapy consisting single-session photodynamic therapy (PDT), intravitreal Avastin (bevacizumab) and intravitreal triamcinolone (IVTA) is a safety and effective treatment for neovascular age-related macular degeneration (AMD). No single therapy completely addresses all of the ways that neovascular AMD works to...

Full Article


Visudyne
Jun 17, 2009
QLT, maker of the drug Visudyne (verteporfin) used during photodynamic therapy (PDT), announced that twelve-month results from the Phase II Mont Blanc study were presented at the European Society of Ophthalmology in June 2009. Mont Blanc is the European arm of the global Summit clinical trial program which investigates the efficacy and safety...

Full Article


Choroidal neovascularization
May 22, 2009
Positive results of a phase 1 clinical study evaluating E10030, a novel anti-platelet derived growth factor (anti-PDGF) in conjunction with an anti-vascular endothelial growth factor (anti-VEGF), to treat wet age-related macular degeneration (wet AMD). Anti-PDGF therapy resulted in enhanced visual outcome and was associated with significant...

Full Article


Macular degeneration
May 22, 2009
Volociximab, an alpha-5 beta-1 integrin antagonist, combined with Lucentis (ranibizumab) treatments for wet age-related macular degeneration is showing a favorable safety profile in early phase 1 studies, according to a poster presentation at the 2009 Association for Research in Vision and Ophthalmology meeting. Baruch D. Kupperman, MD, and...

Full Article


Macular degeneration
May 19, 2009
A retrospective record review of patients undergoing same-day triple therapy consisting of photodynamic therapy, steroid injection, and Avastin (bevacizumab) reports that patients with neovascular age-related macular degeneration (AMD) maintained good visual acuity (VA) and central macular thickness after 13 months of follow-up. PDT with...

Full Article


Visudyne
Apr 22, 2009
A new study finds that combination therapy with Avastin and photodynamic therapy (PDT) for patients with choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) led to improved vision for most patients and required fewer retreatments than is usually required using monotherapy. PDT with Visudyne (verteporfin) was the...

Full Article


SELECT PAGE
First <<  1 2 3 4   >> Last
Most Popular
Less - past - More